News

Idenix Pharmaceuticals Inc v (1) Gilead Sciences8 November 2016Andrew Lykiardopoulos QC, Tom Moody-Stuart QC and William Duncan acted for the respondents, Gilead, alongside Justin Turner QC, in this appeal concerning Idenix’ patent for anti-viral nucleoside analogues for use in treating Hepatitis C virus infection. At first instance, the judge (Arnold J) had found the patent invalid for AgrEvo-type obviousness and insufficiency (both classical […]
Glaxo Wellcome UK Ltd (t/a Allen and Hanburys) v Sandoz Ltd [2016] EWHC 2743 (Ch)2 November 2016This Application forms part of an ongoing and large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to asthma inhalers. Glaxo allege trade mark infringement of its EUTM colour per se mark and passing off in relation to its Seretide Acuhaler asthma inhalers as against Sandoz and […]
Napp Pharmaceutical Holdings Ltd v (1) Dr Reddy’s Laboratories (UK) Ltd (2) Sandoz Ltd (2016)1 November 2016 James Abrahams QC and Henry Ward represented the Appellant, Napp, in this appeal concerning Napp’s patent for a transdermal patch for delivery of the analgesic drug buprenorphine. At first instance the judge had held that the patches produced by the Defendants, Dr Reddy’s and Sandoz, did not infringe Napp’s patent because they used patches with […]
Thoratec Europe Ltd v AIS GMBH Aachen Innovative Solutions (2016)26 October 2016Daniel Alexander QC appeared for the Claimant, Thoratec, and James Mellor QC for the Defendant, AIS, in this action concerning AIS’s patents for a catheter device involving a magnetic ‘clutch’. Thoratec initially sought to invalidate both patents in their entirety and later sought a declaration of non-infringement by reference to a Product Description. Thoratec claimed […]
8 New Square awarded IP, IT and Media set of the year by The Legal 500 UK25 October 2016The Legal 500 UK announced yesterday that they have have awarded 8 New Square Set of the Year in IP, IT and Media & Entertainment,